Make an enquiry
Refer a patient
HCP Logout

We noticed you are on our AU page. Want to switch regions? Choose from the options:

UK
ES
Find a centre
Find a doctor
Make an enquiry
Refer a patient

We noticed you are on our AU page. Want to switch regions? Choose from the options:

UK
ES
Find a centre
Find a doctor

Non-melanoma (SCC, BCC, Merkel)

Non-melanoma (SCC, BCC, Merkel)
2025-06-03T00:00:00.000+10:00
Ongoing

I-MAT

I-MAT
Non-melanoma (SCC, BCC, Merkel)

Immunotherapy Merkel Adjuvant Trial: A randomised, placebo-controlled, phase II trial of adjuvant Avelumab in patients with stage I-III Merkel cell carcinoma

Immunotherapy Merkel Adjuvant Trial: A randomised, placebo-controlled, phase II trial of adjuvant Avelumab in patients with stage I-III Merkel cell carcinoma

Trial overview

Clinical Area

Medical Oncology

Disease

Non-melanoma (SCC, BCC, Merkel)

Disease site

Skin

Study Phase

II

Trial Identifiers

Registration number: NCT04291885

https://clinicaltrials.gov/study/NCT04291885

GenesisCare Location(s)
Principal Investigator(s)
Radiation Oncologist

Dr Gerry Adams

BSc (Hons), MBChB, MRCP (UK), FRCR, FRANZCR

Dr Gerry Adams
location pin icon

Bundaberg (Oncology)

View Profile
Profile Image - Dr Gerry Adams

Clinical trials enquiries

Thank you for submitting.

We will be in touch within 24 hours

An unexpected error has occurred.

You will need to complete the form again, sorry for the inconvenience.

How can we help?

If you have a medical emergency please call 000. If you have an urgent request and would like to speak to our staff, please contact one of our centres directly.

* Indicates a required field.


 

Disclaimer:

This website is provided for information purposes only. Nothing on this website is intended to be used as medical advice, or to diagnose, treat, cure or prevent any disease. It should not be used as a substitute for your own health professional's advice. Any medical procedure or treatment carries risks. Before proceeding with treatment, you should discuss the risks and benefits of the treatment with an appropriately qualified health practitioner. Individual treatment outcomes and experiences will vary.